STOMACH AND DUODENUM: Edited by Mitchell L. SchubertUpdates on management of nonvariceal upper gastrointestinal bleedingAwadalla, Mohanad S.a,*; Desimone, Michaelb; Wassef, WahidbAuthor Information aInternal Medicine Residency bGastroenterology Department, University of Massachusetts Medical Memorial Center, Worcester, Massachusetts, USA Correspondence to Mohanad S. Awadalla, MD, Internal Medicine Residency, University of Massachusetts Medical Memorial Center, 55 Lake Ave N, Worcester, MA 01655, USA. Tel: +1 774 479 6604; e-mail: Mohanad.Awadalla@umassmemorial.org Current Opinion in Gastroenterology: November 2019 - Volume 35 - Issue 6 - p 517-523 doi: 10.1097/MOG.0000000000000582 Buy Metrics Abstract Purpose of review Upper gastrointestinal bleeding (UGIB) is a common and life-threatening condition in the United States and worldwide. Recent findings There have been several exciting recent advances in the endoscopic management of UGIB. One such advance is the recent approval of Hemospray by US Food and Drug Administration in May 2018. Another one is the emerging role of video capsule endoscopy as a triage and localization tool for UGIB patients. Finally, the development of new reversal agents for antithrombotic medications is an important advance in the management of life-threatening upper gastrointestinal bleed. Summary In this article, we will broadly review the management of nonvariceal UGIB, focusing primarily on the data addressing these new advances. Copyright © 2019 Wolters Kluwer Health, Inc. All rights reserved.